KensaGroup creates, launches and develops leading edge intellectual property platforms into successful technology-based businesses. KensaGroup uses a proprietary approach to identify and evaluate promising discoveries from universities and corporate research initiatives, then creates the necessary scientific, institutional, and financial bridges that lead from initial discovery to successful commercialization.
KensaGroup co-founder Tony Eisenhut discusses successful characteristics of entrepreneurs.
KensaGroup co-founder Bruce Ganem discusses the diferent challenges scientists face in product invention versus execution of a company.
06.19.17 - GNS Healthcare announces collaboration with Genentech for development of novel cancer therapies ...more
06.07.17 - Grainful closes $3.3million round of financing as Americans embrace savory oats...more
04.04.17 - GNS taps nationally regarded epidemiologist to put discoveries from causal machine learning and simulation platform in clinical context ...more
03.03.17 - Tukek Holding leads new biorefinery complex in Adana that will incorporate Novomer technology ...more
02.27.17 - Supercritical Carbon Dioxide–Based Sterilization of Decellularized Heart Valves...more
01.30.17 - Men's Journal chooses Grainful entrees as healthy and delicious...more
01.26.17 - Grainful launches three new frozen entree flavors...more
KensaGroup, LLC
2415 N. Triphammer Road
Ithaca, NY 14850
phone: 1.607.330.2307
Fax: 1.607.330.2319